Cargando…
Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats
Parkinson’s disease (PD) is a dopaminergic-related pathology in which functioning of the basal ganglia is altered. It has been postulated that a direct receptor-receptor interaction – i.e. of dopamine D(2) receptor (D(2)R) with adenosine A(2A) receptor (A(2A)R) (forming D(2)R-A(2A)R oligomers) – fin...
Autores principales: | Fernández-Dueñas, Víctor, Taura, Jaume J., Cottet, Martin, Gómez-Soler, Maricel, López-Cano, Marc, Ledent, Catherine, Watanabe, Masahiko, Trinquet, Eric, Pin, Jean-Philippe, Luján, Rafael, Durroux, Thierry, Ciruela, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283650/ https://www.ncbi.nlm.nih.gov/pubmed/25398851 http://dx.doi.org/10.1242/dmm.018143 |
Ejemplares similares
-
Uncovering Caffeine’s Adenosine A(2A) Receptor Inverse Agonism in Experimental Parkinsonism
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2014) -
Revealing Adenosine A(2A)-Dopamine D(2) Receptor Heteromers in Parkinson’s Disease Post-Mortem Brain through a New AlphaScreen-Based Assay
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2019) -
Original Fluorescent Ligand-Based Assays Open New Perspectives in G-Protein Coupled Receptor Drug Screening
por: Cottet, Martin, et al.
Publicado: (2011) -
Decreased striatal adenosine A(2A)-dopamine D(2) receptor heteromerization in schizophrenia
por: Valle-León, Marta, et al.
Publicado: (2020) -
PBF509, an Adenosine A(2A) Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders
por: Núñez, Fabiana, et al.
Publicado: (2018)